Peptide LexiconAll compounds

Thymulin: The Zinc-Dependent Thymus Hormone — What It Is, How It Was Found and What the Research in People Shows

Thymulin is a nine-amino-acid hormone made by the thymus, and it only works with a zinc atom bound to it. It was found in the 1970s, falls with age, and is studied mostly in mice — as an anti-inflammatory signal, a gene-therapy target and, in people, as a marker of zinc status. No trial has given it to anyone as a treatment.

Natural thymus hormoneNot approved as a medicine anywhere this entry foundNo treatment trial registered

Caroline S · Published 2026-11-19

Length

9 amino acids — C33H54N12O15, molecular weight 858.9 for the zinc-free peptide (PubChem CID 71300623)

Sequence

pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (the first residue is pyroglutamate), as given by PubChem's structure for 'thymulin'

Origin

Made by the epithelial cells of the thymus; described in the 1970s by J.-F. Bach's group in Paris as the serum thymic factor

Last reviewed

2026-11-19

What is it good for?

In the body, thymulin is one of the signals the thymus sends to help T cells mature, and it needs a zinc atom to work at all. As a compound, it is studied mostly in mice — as an anti-inflammatory and pain-reducing signal and, in a 2026 study, as a brake on age-related inflammation in cancer models. In people its main use so far is as a blood measurement that tracks zinc status. No trial has tested it as a treatment.

Illustration: An illustrative ball-and-stick model with a copper-coloured central atom on a white surface.
Illustration

What it is

Thymulin is a hormone of nine amino acids made by the epithelial cells of the thymus. Its chain is pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — the first residue is pyroglutamate, a ring-closed form of glutamine (PubChem CID 71300623). It was first described in the 1970s by Jean-François Bach's group in Paris as the facteur thymique sérique (FTS, serum thymic factor), a substance in blood that helped immature T cells take on mature markers.

Property Value Source
Sequence pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn PubChem CID 71300623
Length 9 amino acids —
Formula (zinc-free) C33H54N12O15 PubChem
Molecular weight 858.9 PubChem
Active form One zinc atom per peptide (FTS-Zn) PMID 6957870

Why zinc is the whole story

The name thymulin belongs to the zinc-bound form. In 1982, Dardenne and colleagues stripped metals from both natural and synthetic FTS with a chelating resin and found it lost its activity in their cell test; adding zinc back restored it, best at one zinc atom per peptide (PNAS, PMID 6957870). They proposed "thymulin" for the active FTS-Zn and confirmed the zinc by atomic absorption.

That dependency is why most human studies of thymulin are really studies of zinc. A 2021 rat study compared five ways of detecting marginal zinc deficiency: on the low-zinc diet, serum thymulin activity was 61% lower, against 31% for serum zinc and 18–28% for the other three markers (DiSilvestro et al., PMID 32363520). A 2014 Italian pilot measured thymulin activity in very old people who drank zinc-fortified milk for two months and reports a rise against ordinary milk (Costarelli et al., PMID 24771015). In both, thymulin is the measurement, not the treatment.

What the research in animals shows

A 2014 review from Dardenne and Goya's groups summarises the animal work: thymulin acts on the pituitary, and it and a synthetic analogue reduce inflammation and pain in rodent models; gene-therapy vectors carrying a thymulin analogue (metFTS) have been built and tested in mice without a thymus (Reggiani et al., PMID 24588820). Later mouse papers report the same anti-inflammatory direction in models of sepsis, type 1 diabetes, multiple sclerosis and asthma.

The largest recent study is a 2026 Nature Communications paper from the University of Southern California. It found more inflammatory myeloid cells — making IL-1α, IL-1β, IL-6 and TNF-α — in old mice and in older people. Using parabiosis (joining the circulation of young and old mice), it traced a young-blood factor that suppressed them to thymulin, which acted by blocking NF-κB signalling. Given to mice, thymulin improved tumour control and made tumours respond to anti-PD-L1 therapy in an age-dependent way (Kanemaru et al., PMID 42481458). One author reports an advisory role with Otsuka Pharmaceutical Factory. The human part of the study counted cells; nobody was given thymulin.

What is not established

  • Any treatment effect in people. No registered trial gives thymulin to anyone. ClinicalTrials.gov's single result for the name is an infant zinc-supplementation study (NCT01229579, read 2026-11-19).
  • That an injected dose would behave like the hormone. The active form needs zinc bound to it, and no study was found that tested a supplied peptide in a person.
  • Anti-ageing or immune claims in people. No human study testing either was found.

A note on a confusing literature: "thymulin 5cH" in homeopathy papers is a homeopathic dilution of the hormone, studied in mice (PMID 25439044). It is not the peptide at a dose that could be measured.

Related entries: thymosin alpha-1, the 28-amino-acid thymus peptide approved as a drug in some countries · thymalin, a calf-thymus extract from the St Petersburg programme · thymogen · the family overview at thymosin · and the library's survey of peptides studied for immunity.

Where it stands

Thymulin is a natural hormone with a well-characterised chemistry, a large animal literature and one recent high-profile mouse study. In people it is a laboratory marker of zinc status. Questions about immunity or zinc belong to a doctor; this entry records what the compound is and what has been measured.

Sources opened 2026-11-19: PubChem (CID 71300623); PubMed E-utilities (counts; abstracts of PMIDs 6957870, 32363520, 24771015, 42481458, 24588820, 25439044); ClinicalTrials.gov API v2.

What the research shows

Needs zinc to be active

Dardenne et al. 1982, PNAS (PMID 6957870): the peptide lost activity when metals were removed and regained it with zinc at a 1:1 ratio; the zinc-bound form was named thymulin

Tracks zinc status

DiSilvestro et al. 2021 (PMID 32363520, rats): serum thymulin activity 61% lower on low zinc, against 31% for serum zinc; Costarelli et al. 2014 (PMID 24771015): thymulin activity measured in very old people drinking zinc-fortified milk

Calms age-related inflammation and helps cancer immunotherapy

Kanemaru et al. 2026, Nat Commun (PMID 42481458): mouse models, with inflammatory myeloid cells also counted in older people's blood; thymulin was given to mice, not people

Reduces inflammation and pain

Mouse and rat studies reviewed by Reggiani et al. 2014 (PMID 24588820); no human trial found

Bars show how much of the evidence is in humans, not how well anything works.

Where it stands

Approved as a medicine

No approval found. Drugs@FDA has no thymulin product, and none of the papers read names one (2026-11-19).

Trials

ClinicalTrials.gov: 1 study returned for 'thymulin' — a zinc-supplementation trial in Pakistani infants (NCT01229579) that names it, not a thymulin treatment trial (2026-11-19).

Published record

PubMed: 435 records for 'thymulin' or 'facteur thymique sérique' in title or abstract; 7 also tagged as clinical or randomised trials, and the two newest of those measure thymulin rather than give it (2026-11-19).

Frequently asked questions

What is thymulin?

A small hormone made by the thymus, the organ behind the breastbone where T cells mature. It is a chain of nine amino acids and is only active when a zinc atom is bound to it.

What is thymulin said to be good for?

It is discussed online as a research peptide for immunity and ageing. The published work is mostly in mice: it lowers inflammatory signals and pain in animal models, and a 2026 study found it improved cancer immunotherapy in older mice. No trial has tested it as a treatment in people.

Why does zinc matter for thymulin?

The peptide is inactive on its own. A 1982 study showed it switches on when it binds one zinc atom, and the name thymulin was coined for that zinc-bound form. That is why blood thymulin activity drops when a person or animal is short of zinc.

Has thymulin been tested in humans?

It has been measured in people, not given to them in a registered trial. Studies in elderly people and children track thymulin activity in the blood, mostly as a sign of zinc status.

Is thymulin the same as thymosin or thymalin?

No. All three come from the thymus. Thymosin alpha-1 is a 28-amino-acid peptide approved as a drug in some countries; thymalin is a Russian extract of calf thymus; thymulin is a nine-amino-acid hormone that needs zinc.

Does thymulin decline with age?

Yes, its levels fall as the thymus shrinks with age; the 2026 Nature Communications paper calls it a thymus-derived peptide that declines with age. Whether raising it would do anything for an older person has not been tested.